Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong · Delayed Price · Currency is HKD 1.160
+0.100 (9.43%)
Jun 1, 2026, 3:51 PM HKT
HKG:0950 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 624 | 895 | 836 | 901 | 960 | 1,961 | |
Market Cap Growth | -19.70% | 7.04% | -7.19% | -6.13% | -51.05% | -29.06% |
Enterprise Value | 439 | 715 | 802 | 864 | 750 | 1,783 |
Last Close Price | 1.06 | 1.49 | 1.35 | 1.42 | 1.49 | 2.98 |
PE Ratio | 6.79 | 9.74 | 8.98 | 53.95 | 18.72 | 0.99 |
Forward PE | - | 8.46 | 8.46 | 10.89 | 8.15 | 10.41 |
PS Ratio | 0.43 | 0.62 | 0.60 | 0.86 | 0.78 | 1.55 |
PB Ratio | 0.33 | 0.47 | 0.54 | 0.46 | 0.52 | 0.82 |
P/TBV Ratio | 0.36 | 0.52 | 0.63 | 0.51 | 0.59 | 0.91 |
P/FCF Ratio | 2.34 | 3.36 | 4.22 | 11.17 | 3.61 | 12.26 |
P/OCF Ratio | 1.87 | 2.69 | 3.46 | 8.18 | 3.38 | 9.31 |
PEG Ratio | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
EV/Sales Ratio | 0.31 | 0.50 | 0.57 | 0.82 | 0.61 | 1.41 |
EV/EBITDA Ratio | 2.13 | 3.61 | 3.64 | 6.62 | 3.15 | 105.94 |
EV/EBIT Ratio | 4.05 | 6.48 | 6.01 | 23.98 | 5.89 | - |
EV/FCF Ratio | 1.65 | 2.69 | 4.05 | 10.72 | 2.82 | 11.15 |
Debt / Equity Ratio | 0.16 | 0.16 | 0.15 | 0.10 | 0.09 | 0.11 |
Debt / EBITDA Ratio | 1.49 | 1.49 | 0.98 | 1.42 | 0.65 | 8.39 |
Debt / FCF Ratio | 1.17 | 1.17 | 1.15 | 2.53 | 0.61 | 1.67 |
Net Debt / Equity Ratio | -0.02 | -0.02 | 0.01 | 0.02 | -0.01 | 0.00 |
Net Debt / EBITDA Ratio | -0.20 | -0.20 | 0.05 | 0.25 | -0.11 | -0.62 |
Net Debt / FCF Ratio | -0.15 | -0.15 | 0.05 | 0.41 | -0.10 | -0.06 |
Asset Turnover | 0.47 | 0.47 | 0.51 | 0.37 | 0.38 | 0.37 |
Inventory Turnover | 2.17 | 2.17 | 2.21 | 1.83 | 1.59 | 1.23 |
Quick Ratio | 0.48 | 0.48 | 0.49 | 0.46 | 0.46 | 0.51 |
Current Ratio | 1.03 | 1.03 | 1.02 | 1.01 | 1.00 | 1.04 |
Return on Equity (ROE) | 2.94% | 2.94% | 3.91% | 1.05% | 2.17% | 86.98% |
Return on Assets (ROA) | 2.27% | 2.27% | 3.03% | 0.79% | 2.48% | -1.73% |
Return on Invested Capital (ROIC) | 4.12% | 4.48% | 5.26% | 1.23% | 4.10% | -4.47% |
Return on Capital Employed (ROCE) | 4.70% | 4.70% | 7.20% | 1.60% | 6.00% | -3.50% |
Earnings Yield | 14.73% | 10.27% | 11.13% | 1.85% | 5.34% | 101.34% |
FCF Yield | 42.66% | 29.75% | 23.69% | 8.95% | 27.73% | 8.16% |
Dividend Yield | 4.25% | 3.03% | 3.33% | 1.27% | 1.34% | 2.05% |
Payout Ratio | 30.10% | 30.10% | 18.97% | 63.48% | 47.08% | 1.81% |
Buyback Yield / Dilution | -0.03% | -0.03% | 0.00% | 0.00% | 0.04% | -0.15% |
Total Shareholder Return | 4.21% | 2.99% | 3.33% | 1.27% | 1.38% | 1.90% |